Direct Meds accepts HSA and FSA payments for all GLP-1 treatment programs and provides receipts and documentation for reimbursement as needed
"For the first time, people living with obesity have access to a GLP-1 treatment in a daily pill, allowing them the choice and flexibility of oral treatment to support their long-term weight management." Professor Naveed Sattar, from the University of Glasgow, said: "The approval of the once-daily oral form of Wegovy (semaglutide) is welcome news for people living with obesity, particularly those who would prefer not to use injections
Improved cardiovascular risk: Evidence suggests Wegovy may reduce the risk of major cardiovascular events in adults with obesity and established heart disease
The medication primarily affects metabolic pathways rather than immune function
You can take it at any time of day, with or without food
Remember, insurance coverage varies from plan to plan, even within the same health insurance company
